Advisory Alpha, LLC Pfizer Inc Transaction History

Advisory Alpha, LLC

$2.51 Billion
Q2 2024

A detailed history of Advisory Alpha, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Advisory Alpha, LLC holds 28,005 shares of PFE stock, worth $830,628. This represents 0.03% of its overall portfolio holdings.

Number of Shares

28,005

Previous 31,067 9.86%

Holding current value

$830,628

Previous $862,000 9.16%

% of portfolio

0.03%

Previous 0.04%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 21, 2024	SELL	$25.26 - $29.6 $77,346 - $90,635	-3,062 Reduced 9.86%	28,005 $783,000
Q1 2024 May 06, 2024	BUY	$25.89 - $29.73 $19,080 - $21,911	737 Added 2.43%	31,067 $862,000
Q4 2023 Jan 23, 2024	BUY	$26.13 - $33.94 $8,492 - $11,030	325 Added 1.08%	30,330 $873,000
Q3 2023 Oct 18, 2023	SELL	$32.09 - $37.51 $68,865 - $80,496	-2,146 Reduced 6.67%	30,005 $995,000
Q2 2023 Jul 25, 2023	BUY	$36.12 - $41.79 $492,568 - $569,890	13,637 Added 73.66%	32,151 $1.18 Million
Q1 2023 May 02, 2023	BUY	$39.39 - $51.28 $48,607 - $63,279	1,234 Added 7.14%	18,514 $755,000
Q4 2022 Jan 30, 2023	SELL	$41.75 - $54.5 $72,060 - $94,067	-1,726 Reduced 9.08%	17,280 $885,000
Q3 2022 Oct 12, 2022	BUY	$43.76 - $53.42 $28,225 - $34,455	645 Added 3.51%	19,006 $832,000
Q2 2022 Jul 15, 2022	BUY	$46.53 - $55.17 $26,708 - $31,667	574 Added 3.23%	18,361 $963,000
Q1 2022 May 02, 2022	BUY	$45.75 - $56.69 $31,567 - $39,116	690 Added 4.04%	17,787 $921,000
Q4 2021 Feb 04, 2022	BUY	$41.32 - $61.25 $195,154 - $289,283	4,723 Added 38.17%	17,097 $1.01 Million
Q3 2021 Nov 09, 2021	BUY	$39.25 - $50.42 $181,806 - $233,545	4,632 Added 59.83%	12,374 $532,000
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $16,051 - $18,183	-447 Reduced 5.46%	7,742 $303,000
Q1 2021 May 10, 2021	BUY	$33.49 - $37.77 $30,107 - $33,955	899 Added 12.33%	8,189 $297,000
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $6,325 - $8,043	189 Added 2.66%	7,290 $268,000
Q3 2020 Nov 06, 2020	BUY	$31.75 - $37.25 $24,955 - $29,278	786 Added 12.45%	7,101 $729,000
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $13,162 - $15,967	-437 Reduced 6.47%	6,315 $242,000
Q1 2020 Apr 29, 2020	SELL	$27.03 - $38.62 $9,920 - $14,173	-367 Reduced 5.16%	6,752 $248 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $921 - $1,046	28 Added 0.39%	7,119 $281 Million
Q3 2019 Nov 13, 2019	SELL	$32.49 - $42.13 $8,025 - $10,406	-247 Reduced 3.37%	7,091 $241,000
Q2 2019 Aug 16, 2019	SELL	$36.98 - $41.52 $33,134 - $37,201	-896 Reduced 10.88%	7,338 $314,000
Q1 2019 May 13, 2019	BUY	$37.5 - $41.2 $11,437 - $12,566	305 Added 3.85%	8,234 $0
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $305,028 - $347,765	7,929 New	7,929 $330,000

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Alpha, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Alpha, LLC with notifications on news.

Account

Advisory Alpha, LLC Pfizer Inc Transaction History